The Wall Street Journal unleashed an editorial over Independence Day weekend that is a devastating takedown of the rush to get all toddlers jabbed with Covid vaccines and boosters.
“In fact, we don’t know if the vaccines are safe and effective,” Allyssia Finley wrote in a WSJ editorial. “The rushed FDA action was based on extremely weak evidence. It’s one thing to show regulatory flexibility during an emergency. But for children, Covid isn’t an emergency. The FDA bent its standards to an unusual degree and brushed aside troubling evidence that warrants more investigation.”
“While adult Covid vaccines clearly met this standard in late 2020, the toddler vaccines don’t,” Finley added.
“Only 209 kids between 6 months and 4 years old have died from Covid—about 0.02% of all virus deaths in the U.S.,” the editorial adds. “About half as many toddlers were hospitalized with Covid between October 2020 and September 2021 as were hospitalized with the flu during the previous winter. More children were hospitalized during the Omicron wave last winter, but hospitalization rates were still roughly in line with the 2019-20 flu season. None of the 5,400 or so toddlers in Moderna’s trial were hospitalized for Covid. Yet at least 15 were hospitalized for non-Covid infections.”
The money line from the editorial should give every concerned parent pause before lining their kids up for endless Covid shots and boosters.
“More troubling, vaccinated toddlers in Pfizer’s trial were more likely to get severely ill with Covid than those who received a placebo,” WSJ notes. “Pfizer claimed most severe cases weren’t ‘clinically significant,’ whatever that means, but this was all the more reason that the FDA should have required a longer follow-up before authorizing the vaccine.”
“Also worrisome: Most kids who developed multiple infections during the trial were vaccinated,” the editorial adds. “This warranted more investigation, since experimental vaccines for other diseases sometimes increase susceptibility to infection.”